11 October
12 October
13 October
14 October
11 October
HALLS |
HEMATOLOGY PROGRAM |
|
||
13.50-14.00 |
OPENING REMARKS OF EHOC 2023 Birol Güvenç, Serdar Bedii Omay, Bülent Zülfikar, Giuseppe Saglio, Osman İlhan |
|
||
14.00 - 14.20 |
Life Time Achivement Award Presentation: Influence of Women on Turkish Hematology |
Chair: Birol Guvenç Speaker: Deniz Sargın(Virtual) |
|
|
14.20-15.20 |
SESSION 1 - AML |
CHAIRS: Zeba Aziz - Serdar Bedii Omay |
|
|
14.20 - 14.30 |
State of the Art - Role of Maintenance Therapy in AML |
Zeba Aziz |
|
|
14.30 - 14.50 |
A Case of AML Given Maintanance Therapy |
Mehmet Yılmaz |
|
|
14.50 - 15.10 |
Induction Therapy Choices and Responses in a Third World Country: A Single Center Study From Pakistan |
Amjad Zafar(Virtual) |
|
|
15.10 - 15.20 |
Future Perspectives |
Naval Daver(Virtual) |
|
|
15.20 - 15.40 |
Life Time Achivement Award Presentation: |
Chair:Gamze Tanrıöver Speaker: Robert Peter Gale |
|
|
15.40-16.10 | SATELLITE SYMPOSIUM The Role of Lenalidomide in the Management of Multiple Myeloma in Light of Clinical Experiences and Future Directions Chair:Mustafa Çetiner Speaker:Tülin Tuğlular |
|
||
|
||||
16.10-16.40 |
POSTER WALK WITH COFFEE BREAK Chair : Mehmet Hilmi Doğu |
|
||
|
||||
Biomedical Analysis of Red Blood Cells in Polycythemia Vera, Application of Raman Spectroscopy |
Weronika Marzena Lebowa |
|
||
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-Center Real-Life Study |
Müzeyyen Aslaner Ak |
|
||
A Rare Cause of Cyanosis: Hemoglobin Kansas |
Metban Mastanzade |
|
||
A Rare Cause of Lymphadenopathy: Kikuchi Fujimoto |
Gülcan Erbaş |
|
||
16.40-18.00 |
SESSION 2 - ALL |
CHAIRS: Serdar Bedii Omay - Fevzi Altuntaş |
||
16.40-16.50 |
State of the Art |
Giovanni Martinelli(Virtual) |
||
16.50-17.10 |
Patient 1 - Presentation and Discussion |
Birol Güvenç |
||
17.10-17.30 |
Elderly Ph+ Patient Sound Feasible? |
Giovanni Marconi |
||
17.30-17.50 |
When to Transplant |
Sabina Chiaretti / Yes(Virtual) – Elias Jabbour / No (Virtual) |
||
17.50-18.00 |
Future Perspectives |
Elias Jabbour(Virtual) |
||
17.00-18-50 |
SESSION 3 - SELECTED ORAL COMMUNICATIONS (ADULT HEMATOLOGY) |
CHAIRS: Giuseppe Saglio -Osman İlhan |
||
18.00-18.10 |
Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients With Relapsed Multiple Myeloma (Ikema): Final Overall Survival Analysis |
Ecenur Güder Arslan |
||
18.10-18.20 |
Increased Carotid Intima Media Thickness As an Indicator of Increased Cardiovascular Risk in Patients With Primary Familial Erythrocytosis |
Alpay Yeşilaltay |
||
18.20-18.30 |
New Molecular Targets in Cancer Cell Bioenergetic Pathways |
Ivan Tyumin |
||
18.30-18.40 |
Changes in Mucosa-Associated Invarıant T Cells (Maıt), Associated Cytokines, and Mr-1+ Cell Number and Phenotype in the Peripheral Blood of Pediatric ITP Patients With and Without Eltrombopag Therapy |
Ekrem Ünal |
12 October
HALLS |
HEMATOLOGY PROGRAM |
|
||
08.15-08.45 |
ORAL COMMUNICATIONS SESSIONS (ADULT HEMATOLOGY) |
Chairs: Emin Kaya - Mehmet Ali Uçar |
||
08.15-08.25 |
Evaluation of Vitamin D Status in Adult Patients With Immune Thrombocytopenia |
Rafiye Çiftçiler |
|
|
08.25-08.35 |
The Role of Adamts13 Activity Levels on Disease Exacerbation or Relapse in Patients With Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of The Phase 3 Hercules and Post-Hercules Studies |
Özgüç Semih Şimşir |
|
|
08.35-08.45 |
Ureteral Amyloidosis: A Case Report of Successful Management With Surgery, Radiation, and Chemotherapy |
İbrahim Halil Açar(Virtual) |
|
|
09.00-10.00 |
ADULT & PEDIATRIC ONCOHEMATOLOGY JOINT (BMT VS CAR T CELL) |
CHAIRS: Khalid Halahleh - Oral Nevruz |
|
|
09.00-09.10 |
State of the Art |
Arnon Nagler(Virtual) |
|
|
09.10-09.30 |
Is Hematopoietic Stem Cell Transplantation Necessary to Consolidate Hematological Remission After CAR-T Therapy? |
Francesco Saglio |
|
|
09.30-09.50 |
Post CAR-T: To Transplant, or Not To Transplant, That’s The Question! |
Koray Yalçın |
|
|
09.50-10.00 |
Future Perspectives |
Fatma Visal Okur |
|
|
10.00-11.00 |
ADULT & PEDIATRIC HEMATOLOGY ON HEMOGLOBINOPATHIES JOINT SESSION |
CHAIRS: Salam Al-Kindi - Fahri Şahin |
|
|
10.00-10.10 |
State of the Art |
Maria Capellini(Virtual) |
|
|
10.10-10.30 |
A Patient Case on Non-Transfusion Dependent Thalassemia |
Ali Taher (Virtual) |
|
|
10.30-10.50 |
Patient 2 - Presentation and Discussion |
Anıl Tombak |
|
|
10.50-11.00 |
Future Perspectives |
Salam Al-Kindi |
|
|
11.00-11.30 |
COFFEE BREAK |
|
||
11.30-12.50 |
SESSION 4 - MM |
CHAIRS: Claudio Cerchione - Evangelos Terpos(Virtual) - Tülin Tuğlular |
|
|
11.30-11.40 |
How I Treat Relapsed Refractory Multiple Myeloma - CAR-T and Bispecific Antibodies |
Claudio Cerchione |
|
|
11.40-11.50 |
Mesurable Residual Disease(MRD) in the Era of Modern Therapies for the Treatment of Múltiple Myeloma |
Roberto Magalhaes |
|
|
11.50-12.05 |
A Case of MM With Extramedullary Plasmacytoma Involving Optic Chiasm |
Alpay Yeşilaltay |
|
|
12.05-12.20 |
Management of Late Relapse With T-Cell Engagers |
Alessandra Romano(Virtual) |
|
|
12.20-12.40 |
"Smoldering Myeloma” To Treat versus Not to Treat? |
Evangelos Terpos (Virtual-No)- Claudio Cerchione (Yes) |
|
|
12.40-12.50 |
Future Perspectives |
Roberto Magalhaes |
|
|
12.50-13.20 | SATELLITE SYMPOSIUM ’’Ruxolitinib Experience in Myelofibrosis Treatment’ Chair: Mustafa Nuri Yenerel Speaker: Elif Birtaş Ateşoğlu |
|
||
13.20-14.20 |
LUNCH BREAK |
|
||
14.20-14.40 |
Life Time Achivement Award Presentation: New Targeted Therapies in Acute Lymphoblastic Leukemia |
Chair: Nilgün Sayınalp Speaker: Dieter Hoelzer |
|
|
14.40-16.00 |
SESSION 5 - CML |
CHAIRS: Naeem Chaudhri -Pia Raanani(Virtual)– A.Emre Eşkazan |
|
|
14.40-14.50 |
CML 2023 - State of the Art and Cutting Edge Issues |
Pia Raanani(Virtual) |
||
14.50-15.10 |
Young, Intolerant and Resistant |
Carmen Fava(Virtual) |
||
15.10-15.30 |
A Patient With Multipl TKI Failure |
Deniz Özmen İbiş |
||
15.30-15.50 |
Now that 2 gen TKIs are becoming generic, is still imatinib the best choice as first line therapy? |
Giuseppe Saglio(Yes) - Tomasz Sacha(No) |
||
15.50-16.00 |
Future Perspectives |
Naeem Chaudhri |
||
16.00-17.20 |
SESSION 6 - CLL |
CHAIRS: Ahmad Ibrahim - Sevgi Kalayoğlu Beşışık |
||
16.00-16.10 |
Treatment of CLL in 2023 |
Antonio Cuneo(Virtual) |
||
16.10-16.30 |
Patient 1 - Presentation and Discussion |
Argyris Symeonidis(Virtual) |
||
16.30-16.50 |
Patient 2 - Presentation and Discussion |
Fatma Eda Nuhoğlu Kantarcı |
||
16.50-17.00 |
Combo Therapy |
Ahmad Ibrahim |
||
17.00-17.10 |
Mono Therapy |
Gerardo Musuraca |
||
17.10-17.20 |
Future Perspectives |
Alessandra Ferrajoli(Virtual) |
|
|
17.20-17.50 |
POSTER WALK WITH COFFEE BREAK Chair: Hüseyin Saffet Beköz |
|||
Reaction of the Circulating Regulatory T Cells After Chemoradiation Therapy of Hodgkin Lymphoma |
Angelika Melnikova |
|||
Infection Rates Across the Autologous Stem Cell Transplantation With Reflection of Multiple Myeloma Induction Story in Turkey |
Simge Erdem |
|||
Characterization and Management of Patients With Hereditary Factor X Deficiency: A Retrospective Single Center Experience |
Nigar Abdullayeva |
|||
Localized Al Amyloidosis of the Urinary Bladder Presenting With Painless Massive Hematuria |
Kıvanç Koruk |
|||
Syndrome of Inappropriate Antidiuretic Hormone Secretion As Central Nervous System Lymphoma Relapse Sign of Nodal Diffuse Large B-Cell Lymphoma |
Nur Seda İbili Çetinkaya |
|||
Development of Giant Plasmacytoma in a Patient With Bone Marrow Responce During Treatment: A Case Report |
Rafiye Çiftçiler |
|||
SESSION 7 - MPN'S |
CHAIRS: Tariq Mughal - Rajko Kusec - Gülsüm Özet |
|
||
17.50-18.00 |
State of the Art |
Tariq Mughal |
||
18.00-18.20 |
Patient 1 - Presentation and Discussion |
Alessandro Lucchesi(Virtual) |
||
18.20-18.40 |
Patient 2 - Presentation and Discussion |
Selami Koçak Toprak(Virtual) |
||
18.40-19.00 |
First-Line Treatment Choice for a Young PV Patient - HU vs. IFN |
Rajko Kusec - A. Emre Eşkazan |
||
19.00-19.10 |
Future Perspectives |
Danilla Cilloni |
13 October
HALLS |
HEMATOLOGY PROGRAM |
|
||
08.10-08.50 |
ORAL COMMUNICATIONS SESSIONS (ADULT HEMATOLOGY) |
Chair: Ferit Avcu |
||
08.10-08.20 |
The Relatıonshıp Between Policytemia Vera and Metabolic Syndrome: The Single Center Experience |
Cem Selim |
|
|
08.20-08.30 |
The Outcome of Perıpheral T-Cell Lymphoma Patients Failing First-Line Therapy, From Prospective Cohort of T-Cell Brazil Project |
Carmino De Souza(Virtual) |
|
|
08.30-08.40 |
Global Research Patterns on Blood Donor Deferral: An Analysis of Themes, Trends, and Influence |
Birol Güvenç |
|
|
08.40-08.50 |
A Ghosal Hematodiaphyseal Dysplasıa Case: Excellent Response to Non-Sterodial Anti-Inflamatory Drug Treatment |
Hasan Fatih Çakmaklı |
||
09.00-10.00 |
SESSION 8 - Indolent NHL |
CHAIRS: Burhan Ferhanoğlu - John Lister |
|
|
09.00-09.10 |
Follicular Lymphoma |
Burhan Ferhanoğlu |
|
|
09.10-09.30 |
Follicular Lymphoma - Predicting Aggressive Behavior and Treatment Options |
John Lister |
|
|
09.30-09.50 |
Is There Any Role of SCT in the New Era of Treatment Follicular Lymphoma? |
Murat Özbalak (No) |
|
|
09.50-10.00 |
Future Perspectives |
Stefano Luminari(Virtual) |
|
|
10.00-10.20 |
Life Time Achivement Award Presentation - Survival After Failing ELN Milestones |
Chair : Orhan Ayyıldız Speaker: Rudiger Hehlmann |
|
|
10.20-10.50 | SATELLITE SYMPOSIUM Speakers: Tayfur Toptaş(PNH Diagnosis and Treatment) Anıl Tombak(PNH is an intravascular hemolysis disease) |
|
||
10.50-11.20 |
COFFEE BREAK |
|
||
11.20-12.20 |
SESSION 9 - Aggressive NHL |
CHAIRS: Umberto Vitolo - Olga Meltem Akay |
|
|
11.20-11.30 |
State of the Art of The Treatment of Aggressive Lymphomas |
Umberto Vitolo |
|
|
11.30-11.50 |
Transformed Follicular Lymphoma |
Elif Birtaş Ateşoğlu |
|
|
11.50-12.10 |
Role of ASCT in Treatment of R/R Lymphoma Patients in Resource Limited Countries |
Adriatik Berisha |
|
|
12.10-12.20 |
Future Perspectives |
Gerardo Musuraca |
|
|
12.20-13.20 |
SESSION 10 - HL |
CHAIRS: Carmino De Souza(Virtual) – Leylagül Kaynar |
|
|
12.20-12.30 |
Treatment of Classical Hodgkin Lymphoma |
Carmino De Souza(Virtual) |
|
|
12.30-12.50 |
Patient 1 - Presentation and Discussion |
Shahla Shabanova |
|
|
12.50-13.10 |
An Interim PET Positive Patient With Advanced Stage Hodgkin Lymphoma |
Tayfur Toptaş |
|
|
13.10-13.20 |
Future Perspectives |
Irina Panovska(Virtual) |
|
|
13.20-14.20 |
LUNCH BREAK |
|||
14.20-15.40 |
SESSION 11 - MDS |
CHAIRS: Moshe Mittelman(Virtual) - Mustafa Çetiner |
||
14.20-14.30 |
State of the Art |
Moshe Mittelman(Virtual) |
||
14.30-14.50 |
Optimizing the Management in Low Risk MDS |
Uwe Platzbecker(Virtual) |
||
14.50-15.10 |
Patient 2 - Presentation and Discussion |
Mustafa Çetiner |
||
15.10-15.30 |
Patient with Polycythemia, Thrombocytopenia and Bone Marrow Failure with A Familial Hematologic Disease |
Moshe Mittelman(Virtual) |
||
15.30-15.40 |
Future Perspectives |
Guillermo Garcia Manero(Virtual) |
||
15.40-16.10 | IDEOGEN AG SATELLITE SYMPOSIUM Chair: Giuseppe Gritti Speaker:Ali Ünal(Clinical Outcomes and T-Follicular Helper Phenotype Response with Belinostat in PTCL) Speaker: Owen A.O’Connor(A 20-Year Journey into the Development of Pralatrexate: What's Next?) |
|||
16.10-16.30 |
Life Time Achivement Award Presentation: A 50 Year Personal Perspective on the Treatment of Acute Leukemia |
Chair : Zafer Gülbaş Speaker: Charles Schiffer |
||
16.30-17.30 |
SESSION 12 - COAGULOPATHIES |
CHAIRS: Drew Provan – Bülent Antmen |
||
16.30-16.40 |
State of the Art |
Drew Provan |
||
16.40-17.00 |
Patient 1 - Presentation and Discussion |
Bülent Antmen |
|
|
17.00-17.20 |
Patient 2 - Presentation and Discussion |
Defne Ay Tuncel |
||
17.20-17.30 |
Future Perspective |
Güray Saydam(Virtual) |
|
|
17.30-18.00 |
POSTER WALK WITH COFFEE BREAK Chair :Vahap Okan |
|
||
Can Radiotherapy Induce a Clinical Response With Occasional Long-Term Remission In Recurrent Granulosa Cell Tumors of the Ovary? |
Ibtehaj Taher Hassan |
|||
Azerbaijan Experience of Haemophilia Care. |
Gunel Alizade |
|||
Autologous Hematopoietc Cell Transplantation (Hct) For Hodgkin Lymphoma, Real World Experience of a Single Center Experience. |
Carmıno De Souza |
|||
A Phase 3 Study To Evaluate the Effıcacy and Safety of Caplacizumab Without First-Line Therapeutic Plasma Exchange in Adults With Immune-Mediated Thrombotic Thrombocytopenic Purpura |
Özgüç Semih Şimşir |
|||
18.00-19.10 |
SESSION 13 - RARE ENTITIES |
CHAIRS: Hanan Hamed - Mustafa Nuri Yenerel |
||
18.00-18.15 |
Clinical Case of Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN |
Hanan Hamed |
||
18.15-18.30 |
Clinical Case of Mastocytosis |
Daniela Cilloni |
||
18.30-18.45 |
Hereditary Hemolytic Anemias:Red Cell Membrane Defects New Insights |
Achilles Iolascon(Virtual) |
||
18.45-19.00 |
Clinical Case of PNH |
Mustafa Nuri Yenerel |
||
19.00-19.10 |
Discussion |
All |
14 October
HALLS |
HEMATOLOGY PROGRAM |
|
||
08.10-08.50 |
ORAL COMMUNICATIONS SESSIONS Chair: Ali Ünal |
|
||
08.10-08.20 |
Long-Term Outcomes of Allogeneıc Stem Cell Transplantation For Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-Center Experince From Turkey |
Ayşe Uysal |
|
|
08.20-08.30 |
Ibrutinib-Obinutuzumab Combination Therapy in the Treatment of Relapsed Nodal Marginal Zone Lymphoma: A Case Study |
Nuray Gül Açar(Virtual) |
|
|
08.30-08.40 |
Real-World (RW) Treatment Patterns and Outcomes in Patients (PTS) with Relapsed/Refractory Multiple Myeloma (RRMM) with at Least One Prior Therapy in Turkey |
Özgür Pektaş |
|
|
09.00-10.00 |
SESSION 14 - SUPPORTIVE CARE |
CHAIRS: Claudio Cerchione - Mustafa Çetiner -Mehmet Sönmez |
|
|
09.00-09.15 |
Febrile Neutropenia |
Şiran Keske |
|
|
09.15-09.30 |
Anemia and Transfusion-Medicine |
Birol Güvenç |
|
|
09.30-09.45 |
Pain Management |
Halil Çetingök |
|
|
09.45-10.00 |
The “Problem” of Survivors: How to Manage Them and How to Monitor Long-Term Adverse Events |
Ajai Chari(Virtual) |
|
|
10.00-10.20 |
Life Time Achivement Award Presentation: |
Chair: Şehmus Ertop Speaker: Hagop Kantarjian(Virtual) |
|
|
10.20-10.50 | SATELLITE SYMPOSIUM "Open a New Dimension in Multiple Myeloma Treatment with Darzalex" Chair:Birol Güvenç Speaker:Şebnem İzmir Güner |
|
||
10.50-11.20 |
POSTER WALK WITH COFFEE BREAK Chair : Demet Çekdemir |
|
||
Cutaneous Richter Transformation in the 16th Year of Follicular Lymphoma Diagnosis |
Ulviyya Hasanzade |
|
||
Retrospective Evaluation of Bone Marrow Findings in Autoimmune Hemolytic Anemias |
Eren Arslan Davulcu |
|
||
Reactivation of Hepatitis B in a Patient With Untreated Chronic Lymphocytic Leukemia |
Sinan Demircioğlu |
|
||
Ibrutınıb Related Neuropathy: A Case Report |
Zeynep Tuğba Güven |
|
||
A Rare Intersection: Coexistence of Breast Cancer and Sickle Cell Disease in A 40 - Year-Old Female - A Case Report |
İdil Yürekli |
|||
11.20-11.50 | SATELLITE SYMPOSIUM "Reblozyl changes the blood transfusion needs for patients with beta thalassemia and MDS " Chair:Birol Güvenç Speakers: Mustafa Çetiner - Bülent Antmen |
|||
11.50-12.40 |
SESSION 15 - BONE MARROW FAILURE |
CHAIRS: Ahmad Ibrahim – Işık Kaygusuz Atagündüz |
||
11.50-12.10 |
Aplastic Anemia |
Régis Peffault de Latour (Virtual) |
||
12.10-12.30 |
Severe Aplastic Anemia |
Ahmet Mert Yanık |
||
12.30-12.40 |
Future Perspectives |
Régis Peffault de Latour |
||
12.40-13.00 |
Life Time Achivement Award Presentation- Key Factors For the Success of Clinical Research Networks in Myeloproliferative |
Chair : Siret Ratip Speaker: Tiziano Barbui |
||
13.00-14.00 |
LUNCH BREAK |
|||
14.00-15.30 |
SESSION 16 - CELLULAR THERAPY |
CHAIRS:Jean François Rossi– Elif Birtaş Ateşoğlu |
||
14.00-14.20 |
The Future of Cell Therapy of Haematologic Cancers |
Robert Peter Gale |
||
14.20-14.40 |
A Pivotal Study Report of CNCT19 (Inaticabtagene Autoleucel) Treatment in Adult R/R B-cell ALL in China. |
Lv Lulu (Virtual) |
||
14.40-15.00 |
Dendritic Cells in Oncology |
Angelika Melnikova |
||
15.00-15.10 |
Stem Cell Transplantation in Solid Oncology. A Clinical Case |
Anastasia Mamonova |
||
15.10-15.25 |
Adoptive Immunotherapy in Oncology |
Lyudmila Grivtsova |
||
15.25-15.30 |
Conclusions |
Jean François Rossi |
||
15.30-16.45 |
SESSION 17 - AI IN MEDICINE |
CHAIRS: Moshe Mittelman(Virtual) – Mehmet Ali Özcan |
||
15.30-15.40 |
Introductory Presentation |
Moshe Mittelman(Virtual) |
||
15.40-16.00 |
The Application of AI to Thrombocytopenia |
Drew Provan |
||
16.00-16.30 |
CPi-Clalit Proactive and Preventative Intervention |
Doron Netzer(Virtual) |
||
16.30-16.45 |
Discussion |
All |
||
16.45 |
CLOSING REMARKS OF EHOC 2023 |
|